Avonoid
Tablet
UniMed UniHealthGeneric:
Micronised Diosmin + HesperidinWeight:
450 mg+50 mgbest Price:
? 8.00Generic
Micronised Diosmin + Hesperidin
Contraindications
Some cases of routine gastric disorders and neurovegetative disorders (feeling of discomfort) have been reported. In this cases discontinuation of treatment is not required.
Side Effects
Experimental studies have not shown any teratogenic effect in animals. In human beings, no harmful effect has so far been reported. In the absence of data concerning excretion into breast milk, breast feeding is not recommended during treatment.
Pregnancy And Lactation
If the hemorrhoidal symptoms do not disappear within 15 days, patient should ask doctor for advice. Diosmin (up to 900 mg/day) has been administered to a small number of breast cancer patients who were experiencing lymphedema following surgical and nodal irradiation treatment with resultant reduction of arm edema but no effect on the cancer. Animal studies and more than 20 years of clinical use in Europe have not found any evidence of carcinogenicity or mutagenicity when the components of Diosmin & Hesperidin are used as recommended. As a precaution, Diosmin & Hesperidin is not recommended for patients with a history of cancer since no specific studies have been performed in this population.
Therapeutic
Keep below 30�C temperature, away from light & moisture. Keep out of the reach of children.
Over The Counter Products
